OBJECTIVE: The main goal of this study was to construct a prognostic model for HIV seroconversion among injection drug users (IDUs) using easy-to-measure risk indicators. DESIGN: Cox proportional hazards regression modeling was used for risk stratification in a heterogeneous population of IDUs with regards to HIV risk-taking behaviors. METHODS: Subjects were recruited in a prospective cohort of IDUs followed between September 1992 and October 2001. A total of 1602 men, seronegative at enrollment with at least 1 follow-up visit, were included in the analyses. Only variables that consistently predict HIV seroconversion in several settings were considered. The final model was used to assign a risk score for each participant. RESULTS: Three risk indicators were included in the risk score to predict HIV seroconversion: unstable housing, average cocaine injections per day, and having shared a syringe with a known HIV-positive partner. Kaplan-Meier survival functions were generated and risk score values stratified in 3 groups. HIV incidence rates per 100 person-years were as follows: 0.91 (95% CI, 0.55-1.52) for the low-risk group, 3.10 (95% CI, 2.49-3.84) for the moderate-risk group, and 7.82 (95% CI, 6.30-9.73) for the high-risk group (log-rank P value < 0.0001). CONCLUSION: If validated in other settings, this risk score may improve the prediction of outcome and allow more accurate stratification in clinical trials.
OBJECTIVE: The main goal of this study was to construct a prognostic model for HIV seroconversion among injection drug users (IDUs) using easy-to-measure risk indicators. DESIGN: Cox proportional hazards regression modeling was used for risk stratification in a heterogeneous population of IDUs with regards to HIV risk-taking behaviors. METHODS: Subjects were recruited in a prospective cohort of IDUs followed between September 1992 and October 2001. A total of 1602 men, seronegative at enrollment with at least 1 follow-up visit, were included in the analyses. Only variables that consistently predict HIV seroconversion in several settings were considered. The final model was used to assign a risk score for each participant. RESULTS: Three risk indicators were included in the risk score to predict HIV seroconversion: unstable housing, average cocaine injections per day, and having shared a syringe with a known HIV-positive partner. Kaplan-Meier survival functions were generated and risk score values stratified in 3 groups. HIV incidence rates per 100 person-years were as follows: 0.91 (95% CI, 0.55-1.52) for the low-risk group, 3.10 (95% CI, 2.49-3.84) for the moderate-risk group, and 7.82 (95% CI, 6.30-9.73) for the high-risk group (log-rank P value < 0.0001). CONCLUSION: If validated in other settings, this risk score may improve the prediction of outcome and allow more accurate stratification in clinical trials.
Authors: Costin Tomescu; Fuh-Mei Duh; Michael A Lanier; Angela Kapalko; Karam C Mounzer; Maureen P Martin; Mary Carrington; David S Metzger; Luis J Montaner Journal: AIDS Date: 2010-09-10 Impact factor: 4.177
Authors: Krystal Colón; David W Speicher; Peter Smith; Mack Taylor; David S Metzger; Luis J Montaner; Costin Tomescu Journal: J Acquir Immune Defic Syndr Date: 2019-02-01 Impact factor: 3.731
Authors: Julie Bruneau; Mark Daniel; Michal Abrahamowicz; Geng Zang; François Lamothe; Jean Vincelette Journal: Am J Epidemiol Date: 2011-03-01 Impact factor: 4.897
Authors: Lillian B Brown; William C Miller; Gift Kamanga; Jay S Kaufman; Audrey Pettifor; Rosalie C Dominik; Naomi Nyirenda; Pearson Mmodzi; Clement Mapanje; Francis Martinson; Myron S Cohen; Irving F Hoffman Journal: AIDS Behav Date: 2012-07
Authors: Costin Tomescu; Kelly E Seaton; Peter Smith; Mack Taylor; Georgia D Tomaras; David S Metzger; Luis J Montaner Journal: J Acquir Immune Defic Syndr Date: 2015-03-01 Impact factor: 3.731
Authors: Mark H Kuniholm; Malvina Aladashvili; Carlos Del Rio; Ketavan Stvilia; Nino Gabelia; Rohit A Chitale; Tengiz Tsertsvadze; Kenrad E Nelson Journal: Subst Use Misuse Date: 2008 Impact factor: 2.164
Authors: Carter A Lennon; Jennifer A Pellowski; Angela C White; Seth C Kalichman; David J Finitsis; Viana Turcios-Cotto; Alefiyah Pishori; Nicole M Overstreet; Dominica Hernandez; Ann Kane; David M Kelly; Gertrude A Lanouette Journal: AIDS Care Date: 2013-01-10